An Observational Study of Fungal Biomarkers (MK-0000-089)

Not Recruiting

Trial ID: NCT00854607


The purpose of this study is to evaluate the relationship between fungal biomarker levels during anti-fungal therapy and the success of treatment for fungal infection. The primary hypothesis is that over the initial two weeks of anti-fungal therapy, fungal biomarkers from participants with invasive aspergillosis (IA) will be lower for those with a successful clinical outcome compared to those with a failed clinical outcome.

Official Title

A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis

Stanford Investigator(s)

Wes (Janice) Brown
Wes (Janice) Brown

Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

Dora Ho
Dora Ho

Clinical Professor, Medicine - Infectious Diseases


Inclusion Criteria:

   - Is 16 years of age or older

   - Female is either post-menopausal, surgically sterilized, willing to use 2 adequate
   methods of birth control, or agrees to abstain from heterosexual activity throughout
   the study

   - Female of child bearing potential must have a negative pregnancy test

   - Male is surgically sterilized, agrees to use an adequate method of contraception, or
   agrees to abstain from heterosexual activity for the duration of the study

   - Has possible, probable, or confirmed invasive aspergillosis (IA)

   - Has had a computed tomography (CT) or magnetic resonance imaging (MRI) scan 72 hours
   prior to initiation of anti-fungal therapy

Exclusion Criteria:

   - Has had hemodialysis using cellulose membrane within 2 weeks of study start


other: No Intervention

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
BMT Referrals

New Trial Alerts

Receive email alerts when trials open to patients.